1. Home >
  2. Companies >
  3. Acquired >
  4. Life Science >
  5. United States >
  6. Massachusetts >
  7. Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets

Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets Overview

Life ScienceCompany

Where is Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets headquartered?

Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets is headquartered in Cambridge, Massachusetts.

What sector is Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets in?

Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets is a life science company.

Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets

Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets

Cambridge, Massachusetts 02139
United States,

Syros Pharmaceuticals' Tamibarotene clinical and non-clinical assets are retinoic acid receptors. Syros Pharmaceuticals' Tamibarotene clinical and non-clinical assets are based in Cambridge, Massachusetts.


Company Summary

SECTOR

Life Science


Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Syros Pharmaceuticals - Tamibarotene clinical and non-clinical assets

Massachusetts Companies , Life Science Companies , United States Companies , Massachusetts Life Science Companies , Massachusetts Life Science with Acquisitions , Massachusetts Life Science with Divestitures

Related Lists for Massachusetts Companies

Largest Massachusetts Companies , Acquisitive Massachusetts Companies , Recently Acquired Massachusetts Companies , Recently Sold Massachusetts Companies , Private Massachusetts Companies , Public Massachusetts Companies , Acquired Massachusetts Companies , PE Backed Massachusetts Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Solution for

Product

Company

Legal